D2d enrolls 500th participant

Our Story
D2d enrolls 500th participant

D2d enrolls 500th participant

D2d enrolls 500th participant

August 28, 2014|

A participant at the Atlanta VA Medical Center site is the 500^thparticipant enrolled in D2d. The participant completed the study.

SHARE IT:

Related Posts

D2d Publication: Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes
D2d Publication: Effects of vitamin D supplementation on insulin sensitivity and secretion in prediabetes
D2d Publication: Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial
D2d Publication: Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study
Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D?
D2d Publication: Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study
Untangling the Gordian Knot of Vitamin D Supplementation and Type 2 Diabetes Prevention
D2d Publication: Reproducibility of a prediabetes classification in a contemporary population
D2d Publication: Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes
Results of The Primary Outcome Are Unveiled
D2d Publication: Use of Electronic Health Records to Recruit People at High Risk of Type 2 Diabetes
D2d Participant Visits Completed
D2d Publication: Financial Management of large, multi-center trials
D2d Establishes a Participant Registry
D2d Publication: Baseline characteristics of the D2d cohort

Comments are closed.

D2d | Division of Endocrinology, Diabetes and Metabolism | Tufts Medical Center | Boston MA
Copyright © D2d study. All rights reserved.